July 10, 2016 |
Pennsylvania's medical marijuana bill was signed into law in April, but it will be two years before most patients can take advantage of it. That's how long the state has to come up with specific regulations to build this industry. Judging from the range of topics and speakers Friday at a daylong "Medical Marijuana Regulatory-Palooza," it may take at least that long to figure it all out. "We are about to do something that has never been done before," said State Sen. Daylin Leach (D., Montgomery)
July 9, 2016 |
Men with metastatic prostate cancer have a surprisingly high rate of inherited mutations in DNA-repair genes, suggesting that all men with such advanced prostate cancer should be considered for genetic testing, a new study concludes. Genetic testing is not recommended for men with cancer confined to the prostate - or men whose cancer later spreads - because studies have found less than 5 percent have defective DNA-repair genes. But the prevalence of such defects among men who are initially diagnosed with metastatic prostate cancer has been unclear, according to the new study, published Wednesday in the New England Journal of Medicine by researchers from six leading cancer centers in the United States and Britain.
July 3, 2016 |
Pennsylvania this week became the 41st state to pass controversial legislation aimed at making oral cancer drugs more affordable for patients. The bill, which passed both chambers of the legislature unanimously Thursday, was headed to Gov. Wolf, whose office said Friday that he would sign it into law. Out-of-pocket costs for intravenous chemotherapy - which requires going to a medical office for infusions - are much lower than patients' costs...
June 24, 2016 |
Less than 5 percent of adult cancer patients take part in the clinical trials critical to finding new treatments, a network of patient advocates reported Wednesday. The Cancer Support Community, an international group with chapters in major cities, released the numbers at a Philadelphia news conference that highlighted an ongoing campaign to increase awareness in the hope of reducing cancer deaths. The organization surveyed 506 patients and 81 caregivers about their beliefs, experiences, and information related to clinical trial participation.
April 11, 2016 |
Nineteen years ago, Elyce Cardonick got a call about a newly diagnosed lymphoma patient whose fast-growing chest tumor was causing severe breathing problems. The cancer patient was 13 weeks pregnant and had rejected her oncologist's advice to abort before starting toxic chemotherapy. Cardonick, a young maternal-fetal medicine specialist then at Jefferson University Hospital , discovered that little was known about treating cancer during pregnancy. The issue became her calling, inspiring her to create the Pregnancy and Cancer Registry to collect data about treatment and long-term results for both mothers and children.
April 6, 2016
ISSUE | CANCER Help patients now As an institution that cares for many of Pennsylvania's cancer patients, the Penn State Cancer Institute was thrilled about Vice President Biden's "moonshot" to accelerate the development of treatments and cures. But we can't forget about the nearly 700,000 Pennsylvania cancer patients who need treatment today. House Bill 60, the Oral Chemotherapy Parity Act, would provide affordable access to oral anticancer medications. An outdated insurance law makes these medications cost-prohibitive for many patients, especially compared with intravenous chemotherapy.
February 24, 2016 |
Formula Pharmaceuticals Inc., of Berwyn, and Rockland Immunochemicals Inc., in Limerick, announced a collaboration Monday to develop cancer immunotherapies, focusing on Formula's Cytokine Induced Killer (C.I.K.) cell-based chimeric antigen receptor (CAR) technology to treat cancer. Financial terms were not disclosed. Rockland will provide the research staff and a 60,000-square-foot research and development facility to develop and increase Formula's product pipeline, Formula president and CEO Maurits W. Geerlings said.
January 26, 2016
By Robert Graboyes and Thomas Stossel President Obama has put Vice President Biden in charge of a "moonshot" to cure cancer. Biden recently lost his son Beau to the disease, so his sincerity and passion are assured. And everybody - irrespective of political persuasion - can agree that curing this dread disease is a noble pursuit. Unfortunately, the timeworn moonshot analogy is inappropriate. Curing cancer is not at all like landing on the moon. When President John F. Kennedy articulated his moonshot project in May 1961, it was a narrowly focused, clearly defined engineering problem.
January 24, 2016
The United States compares well to six other developed nations on some measures of end-of-life care, such as the percentage of patients who die in the hospital, but we're still on the pricey side, according to the first international comparison of its kind. Ezekiel Emanuel, chair of the department of medical ethics and health policy at the University of Pennsylvania, was senior author of the paper, published Tuesday in the Journal of the American Medical Association. It compared site of death, health-care use, and hospital cost for cancer patients over 65 in Belgium, Canada, England, Germany, the Netherlands, Norway, and the U.S. Among the findings: The U.S. had the lowest proportion of patients die in acute-care hospitals, 22.2 percent.
January 11, 2016
Ellen Stovall, 69, a three-time cancer patient nationally known among physicians, legislators and policymakers as one of the country's most forceful advocates for cancer survivors, died Jan. 5 at a hospital in Rockville, Md. Mrs. Stovall's death was announced by the National Coalition for Cancer Survivorship, where she was president and CEO from 1992 to 2008. Her brother, Stephen Lewis, said she had cardiac ailments related to her radiation and chemotherapy. Mrs. Stovall, a Scranton native, was 24 and the mother of a newborn boy when she learned that she had Stage 4 Hodgkin's lymphoma in 1971.